In this second webinar on the topic of canine atopic dermatitis, Dr. Pieper continues his discussion with a focus on moderate to severe cases of disease. His discussion includes:
- Characteristics of moderate to severe disease
- Current therapeutic options including JAK inhibitors (Apoquel and Zenrelia) and when they should be implemented into treatment plans
- The role of monoclonal antibodies and how Cytopoint can be used as part of patient management
- The ideal cases for allergen specific immunotherapy and testing options
Running time: 1 hr 16 mins (including 16 mins of Q&A)
Approved for 1 hour of CE credit by AAVSB RACE and NY State
You might also like
Hemangiosarcoma - What We Know And How That's Changing The Paradigm Of Treatment And Prevention
11/13/2024
Hemangiosarcoma is a malignant tumor and, historically, associated with a poor long term prognosis....
Read
More
Treating Cancer - It's Not Just Limited To "chemo" Or "radiation"
11/06/2024
There are different approaches to cancer treatment and, for some types of cancer, the therapy may be...
Read
More
Protein-Losing Enteropathy - Therapeutic Management And The Crucial Role Of Nutrition
09/17/2024
In this second session (of a two part series) Dr. Jablonski continues the discussion on patient mana...
Read
More
Mastering IMHA In Dogs - Part I: Approaches To Diagnosis And Standard Management
07/23/2024
This is the first of a two part series on the topic of immune-mediated hemolytic anemia (IMHA) in do...
Read
More
Caring For Chronic Kidney Disease (CKD) In The Dog - Quality Of Life And End Of Life Considerations
07/09/2024
The focus of this session is on maximizing the quality of life of dogs with chronic kidney disease (...
Read
More
Caring For Chronic Kidney Disease (CKD) In The Dog - Key Elements Of A Clinical Management Strategy
06/25/2024
In this second session of a 4-part series on the topic of chronic kidney disease (CKD) in dogs, you...
Read
More
